Novartis CEO Is Going All in With Some Big Bets on R&D

Novartis CEO Is Going All in With Some Big Bets on R&D

Source: 
BioSpace
snippet: 

Since taking over as chief executive officer of Swiss pharma giant Novartis, Vas Narasimhan has been actively reshaping the company to focus on therapies that will drive revenue well into the future.